TuHURA Biosciences, Inc. (HURA) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, TuHURA Biosciences reported revenue of $0. Net income was -$30.1M, or -$0.63 per diluted share. Operating activities generated -$27.6M of cash, leaving -$27.7M of free cash flow. At fiscal year end, TuHURA Biosciences held $27.4M in total assets against $6.4M in total liabilities, including $3.6M of cash and equivalents.
Open the full interactive TuHURA Biosciences financials → Quarterly statements, key ratios, valuation history and price charts.
TuHURA Biosciences Key Stats
| Share Price | $1.81 |
|---|---|
| Market Cap | $115.8M |
| 52-Week Range | $0.44 – $3.15 |
| Shares Outstanding | 64.0 million (basic, 2026 Q2) |
TuHURA Biosciences Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Pre-Tax Income | -$9.1M | -$38.3M | -$22.7M | -$14.6M | $21.7M | -$30.1M |
| Income Tax | — | — | — | — | $3,768 | $1,600 |
| Net Income | -$9.1M | -$38.3M | -$22.7M | -$14.6M | -$21.7M | -$30.1M |
| Diluted EPS | — | — | — | — | -$1.21 | -$0.63 |
TuHURA Biosciences Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Net Income | -$7.1M | -$6.8M | -$7.5M | -$9.2M |
| Diluted EPS | -$0.14 | -$0.14 | -$0.13 | -$0.14 |
TuHURA Biosciences Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.4M | $10.5M | $11.8M | $1.5M | $12.7M | $3.6M |
| Current Assets | $2.9M | $11.8M | $13.3M | $3.3M | $19.6M | $4.6M |
| Total Assets | $2.9M | $13.5M | $15.9M | $4.0M | $20.0M | $27.4M |
| Current Liabilities | — | $2.8M | $4.0M | $3.1M | $5.3M | $5.9M |
| Total Liabilities | $2.7M | $3.0M | $4.2M | $3.2M | $5.4M | $6.4M |
| Shareholders' Equity | $263,214 | $10.6M | $11.8M | $731,000 | $14.6M | $20.9M |
TuHURA Biosciences Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$7.9M | -$18.9M | -$20.4M | -$11.9M | -$14.7M | -$27.6M |
| Cash From Investing | — | $964,000 | — | -$232,000 | -$6.1M | -$1.3M |
| Cash From Financing | $6.6M | $26.0M | $21.6M | $1.9M | $29.8M | $19.9M |
| Free Cash Flow | — | — | — | — | -$14.8M | -$27.7M |
Figures from TuHURA Biosciences' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full TuHURA Biosciences financials page for every line item.
TuHURA Biosciences Company Profile
| Ticker | HURA |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | Tampa, Florida |
| Incorporated in | Nevada |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001498382 |
Frequently Asked Questions
What was TuHURA Biosciences' revenue in fiscal 2025?
TuHURA Biosciences (HURA) reported revenue of $0 for fiscal 2025.
What is TuHURA Biosciences' annual revenue history?
TuHURA Biosciences' annual revenue by fiscal year: 2020: $0; 2021: $0; 2022: $0; 2023: $0; 2024: $0; 2025: $0.
What was TuHURA Biosciences' net income in fiscal 2025?
TuHURA Biosciences reported net income of -$30.1M for fiscal 2025.
What was TuHURA Biosciences' earnings per share (EPS) in fiscal 2025?
TuHURA Biosciences' diluted EPS was -$0.63 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did TuHURA Biosciences generate in fiscal 2025?
TuHURA Biosciences generated -$27.7M of free cash flow in fiscal 2025.
What was TuHURA Biosciences' revenue last quarter?
In its most recent reported quarter (2026 Q2), TuHURA Biosciences reported revenue of $0.
How many shares of TuHURA Biosciences are outstanding?
TuHURA Biosciences reported a weighted average of 64.0 million basic shares outstanding in 2026 Q2.
What is TuHURA Biosciences' market cap?
Based on its latest closing price, TuHURA Biosciences (HURA) has a market capitalization of about $115.8M.
When does TuHURA Biosciences' fiscal year end?
TuHURA Biosciences' fiscal year end, as registered with the SEC, is December 31.
Where is TuHURA Biosciences headquartered?
TuHURA Biosciences lists its business address in Tampa, Florida in its SEC filings.